ワクチン有効性 (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "ワクチン有効性" in Japanese language version.

refsWebsite

Global rank Japanese rank

9nih.gov

4^th place

24^th place

5worldcat.org

5^th place

19^th place

4doi.org

2^nd place

6^th place

1nytimes.com

7^th place

63^rd place

1cdc.gov

218^th place

712^th place

1osf.io

7,153^rd place

low place

1bmj.com

1,226^th place

1,988^th place

1sciencebasedmedicine.org

5,063^rd place

low place

1web.archive.org

1^st place

bmj.com

“Rapid Response: Re: Covid-19: Past infection provides 83% protection for five months but may not stop transmission, study finds”. British Medical Journal. 2021年3月10日閲覧。

cdc.gov

“How flu vaccine effectiveness and efficacy are measured”. Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, US Department of Health and Human Services (2016年1月29日). 2020年5月6日閲覧。

doi.org

Weinberg, Geoffrey A.; Szilagyi, Peter G. (2010-06-01). “Vaccine Epidemiology: Efficacy, Effectiveness, and the Translational Research Roadmap”. The Journal of Infectious Diseases 201 (11): 1607–1610. doi:10.1086/652404. ISSN 0022-1899. https://doi.org/10.1086/652404.
Orenstein, W. A.; Bernier, R. H.; Hinman, A. R. (1988). “Assessing vaccine efficacy in the field. Further observations”. Epidemiologic Reviews 10: 212–241. doi:10.1093/oxfordjournals.epirev.a036023. ISSN 0193-936X. PMID 3066628.
Crislip (2009) cited Monto, Arnold S.; Ohmit, Suzanne E.; Petrie, Joshua G.; Johnson, Emileigh; Truscon, Rachel; Teich, Esther; Rotthoff, Judy; Boulton, Matthew et al. (2009). “Comparative Efficacy of Inactivated and Live Attenuated Influenza Vaccines”. New England Journal of Medicine 361 (13): 1260–1267. doi:10.1056/NEJMoa0808652. ISSN 0028-4793. PMID 19776407.
Crislip (2009) cited Ohmit, Suzanne E.; Victor, John C.; Teich, Esther R.; Truscon, Rachel K.; Rotthoff, Judy R.; Newton, Duane W.; Campbell, Sarah A.; Boulton, Matthew L. et al. (2008). “Prevention of Symptomatic Seasonal Influenza in 2005–2006 by Inactivated and Live Attenuated Vaccines”. The Journal of Infectious Diseases 198 (3): 312–317. doi:10.1086/589885. ISSN 0022-1899. PMC 2613648. PMID 18522501.

nih.gov

pubmed.ncbi.nlm.nih.gov

Clemens, J.; Brenner, R.; Rao, M.; Tafari, N.; Lowe, C. (1996-02-07). “Evaluating new vaccines for developing countries. Efficacy or effectiveness?”. JAMA 275 (5): 390–397. ISSN 0098-7484. PMID 8569019.
Orenstein, W. A.; Bernier, R. H.; Hinman, A. R. (1988). “Assessing vaccine efficacy in the field. Further observations”. Epidemiologic Reviews 10: 212–241. doi:10.1093/oxfordjournals.epirev.a036023. ISSN 0193-936X. PMID 3066628.
Orenstein WA, Bernier RH, Dondero TJ, Hinman AR, Marks JS, Bart KJ, Sirotkin B (1985). “Field evaluation of vaccine efficacy”. Bull. World Health Organ. 63 (6): 1055–68. PMC 2536484. PMID 3879673.
Crislip (2009) cited Monto, Arnold S.; Ohmit, Suzanne E.; Petrie, Joshua G.; Johnson, Emileigh; Truscon, Rachel; Teich, Esther; Rotthoff, Judy; Boulton, Matthew et al. (2009). “Comparative Efficacy of Inactivated and Live Attenuated Influenza Vaccines”. New England Journal of Medicine 361 (13): 1260–1267. doi:10.1056/NEJMoa0808652. ISSN 0028-4793. PMID 19776407.
Crislip (2009) cited Ohmit, Suzanne E.; Victor, John C.; Teich, Esther R.; Truscon, Rachel K.; Rotthoff, Judy R.; Newton, Duane W.; Campbell, Sarah A.; Boulton, Matthew L. et al. (2008). “Prevention of Symptomatic Seasonal Influenza in 2005–2006 by Inactivated and Live Attenuated Vaccines”. The Journal of Infectious Diseases 198 (3): 312–317. doi:10.1086/589885. ISSN 0022-1899. PMC 2613648. PMID 18522501.

ncbi.nlm.nih.gov

Orenstein WA, Bernier RH, Dondero TJ, Hinman AR, Marks JS, Bart KJ, Sirotkin B (1985). “Field evaluation of vaccine efficacy”. Bull. World Health Organ. 63 (6): 1055–68. PMC 2536484. PMID 3879673.
Crislip (2009) cited Ohmit, Suzanne E.; Victor, John C.; Teich, Esther R.; Truscon, Rachel K.; Rotthoff, Judy R.; Newton, Duane W.; Campbell, Sarah A.; Boulton, Matthew L. et al. (2008). “Prevention of Symptomatic Seasonal Influenza in 2005–2006 by Inactivated and Live Attenuated Vaccines”. The Journal of Infectious Diseases 198 (3): 312–317. doi:10.1086/589885. ISSN 0022-1899. PMC 2613648. PMID 18522501.

pmc.ncbi.nlm.nih.gov

Orenstein WA, Bernier RH, Dondero TJ, Hinman AR, Marks JS, Bart KJ, Sirotkin B (1985). “Field evaluation of vaccine efficacy”. Bull. World Health Organ. 63 (6): 1055–68. PMC 2536484. PMID 3879673.
Crislip (2009) cited Ohmit, Suzanne E.; Victor, John C.; Teich, Esther R.; Truscon, Rachel K.; Rotthoff, Judy R.; Newton, Duane W.; Campbell, Sarah A.; Boulton, Matthew L. et al. (2008). “Prevention of Symptomatic Seasonal Influenza in 2005–2006 by Inactivated and Live Attenuated Vaccines”. The Journal of Infectious Diseases 198 (3): 312–317. doi:10.1086/589885. ISSN 0022-1899. PMC 2613648. PMID 18522501.

nytimes.com

Zimmer, Carl (20 November 2020). “2 Companies Say Their Vaccines Are 95% Effective. What Does That Mean? You might assume that 95 out of every 100 people vaccinated will be protected from Covid-19. But that's not how the math works.”. The New York Times 21 November 2020閲覧。

osf.io

“Clearly Defining Re-exposure Protection And Vaccine Efficacy Statistical Results”. OSF Preprints. 2021年3月10日閲覧。

sciencebasedmedicine.org

“Flu Vaccine Efficacy”. Science-Based Medicine (2009年10月9日). 2020年6月1日時点のオリジナルよりアーカイブ。2021年3月2日閲覧。

web.archive.org

“Flu Vaccine Efficacy”. Science-Based Medicine (2009年10月9日). 2020年6月1日時点のオリジナルよりアーカイブ。2021年3月2日閲覧。

worldcat.org

search.worldcat.org

Weinberg, Geoffrey A.; Szilagyi, Peter G. (2010-06-01). “Vaccine Epidemiology: Efficacy, Effectiveness, and the Translational Research Roadmap”. The Journal of Infectious Diseases 201 (11): 1607–1610. doi:10.1086/652404. ISSN 0022-1899. https://doi.org/10.1086/652404.
Clemens, J.; Brenner, R.; Rao, M.; Tafari, N.; Lowe, C. (1996-02-07). “Evaluating new vaccines for developing countries. Efficacy or effectiveness?”. JAMA 275 (5): 390–397. ISSN 0098-7484. PMID 8569019.
Orenstein, W. A.; Bernier, R. H.; Hinman, A. R. (1988). “Assessing vaccine efficacy in the field. Further observations”. Epidemiologic Reviews 10: 212–241. doi:10.1093/oxfordjournals.epirev.a036023. ISSN 0193-936X. PMID 3066628.
Crislip (2009) cited Monto, Arnold S.; Ohmit, Suzanne E.; Petrie, Joshua G.; Johnson, Emileigh; Truscon, Rachel; Teich, Esther; Rotthoff, Judy; Boulton, Matthew et al. (2009). “Comparative Efficacy of Inactivated and Live Attenuated Influenza Vaccines”. New England Journal of Medicine 361 (13): 1260–1267. doi:10.1056/NEJMoa0808652. ISSN 0028-4793. PMID 19776407.
Crislip (2009) cited Ohmit, Suzanne E.; Victor, John C.; Teich, Esther R.; Truscon, Rachel K.; Rotthoff, Judy R.; Newton, Duane W.; Campbell, Sarah A.; Boulton, Matthew L. et al. (2008). “Prevention of Symptomatic Seasonal Influenza in 2005–2006 by Inactivated and Live Attenuated Vaccines”. The Journal of Infectious Diseases 198 (3): 312–317. doi:10.1086/589885. ISSN 0022-1899. PMC 2613648. PMID 18522501.